Hostname: page-component-857557d7f7-bkbbk Total loading time: 0 Render date: 2025-12-04T01:46:53.821Z Has data issue: false hasContentIssue false
  • English
  • Français

Cannabis Consumption as a Prognostic Factor in Schizophrenia

Published online by Cambridge University Press:  02 January 2018

M. J. Martinez-Arevalo ,
A. Calcedo-Ordoñez  and
J. R. Varo-Prieto
M. J. Martinez-Arevalo*
Affiliation:
Alcobendas Mental Health Centre, Madrid
A. Calcedo-Ordoñez
Affiliation:
Department of Psychiatry, University Complutense of Madrid; Department of Psychiatry, Hospital Gregorio Marañón, Madrid
J. R. Varo-Prieto
Affiliation:
Mental Health Center II-B, Navarra, Spain
*
∗ Centro de Salud Mental, C/ Orense No. 5, Alcobendas, Madrid, Spain
Get access Rights & Permissions [Opens in a new window]

Abstract

Data were analysed from 62 schizophrenic patients between 18 and 30 years of age, treated at the community mental health centres in Navarra, who had relapsed and then completed a one-year follow-up study. Factors influencing the course of illness during follow-up were: continuing cannabis consumption; previous cannabis intake; non-compliance with treatment; and stress.

Information

Type
Short Papers
Information
The British Journal of Psychiatry , Volume 164 , Issue 5 , May 1994 , pp. 679 - 681
Copyright
Copyright © 1994 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: APA.Google Scholar
Andreasson, S., Allebeck, P. & Rydemberg, V. (1989) Schizophrenia in users and nonusers of cannabis. Acta Psychiatrica Scandinavica, 79, 505–510.Google Scholar
Barbee, J., Clark, P., Camprazano, M., et al (1989) Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatry service. Journal of Mental and Nervous Diseases, 177, 400–407.Google Scholar
Brady, K. & Gasto, S. (1989) Illicit substance use by acutely psychotic patients. American Journal of Psychiatry, 146, 1349–1350.Google Scholar
Herz, M. & Melville, C. (1980) Relapse in schizophrenia. American Journal of Psychiatry, 137, 801–805.Google Scholar
Knudsen, P. & Vilmar, T. (1984) Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatrica Scandinavica, 69, 162–174.CrossRefGoogle ScholarPubMed
Negrete, S. (1989) Cannabis and schizophrenia. British Journal of Addiction, 84, 349–351.Google Scholar
Negrete, S., Knapp, W., Douglas, D., et al (1986) Cannabis affects the severity of schizophrenic symptoms: result of a clinical survey. Psychological Medicine, 16, 515–520.Google Scholar
Shearn, C. & Fitz, G. (1972) Patterns of drug use in a population of youthful psychiatric patients. American Journal of Psychiatry, 128, 65–71.Google Scholar
Tsuang, H., Simpson, I. & Kanfrol, Z. (1982) Subtypes of drug abuse with psychosis. Archives of General Psychiatry, 39, 141–147.Google Scholar
Turner, W. & Tsuang, M. (1990) Impact of substance abuse on the course and outcome of schizophrenia. Schizophrenia Bulletin, 16, 87–95.Google Scholar

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.